A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.

Specifically, in the PRRT-naive cohort, the ORR reached 60%, while 34.1% of patients showed stable disease. Combining these ...

Students and faculty of UC Santa Barbara’s physics department gathered in Corwin Pavilion for the department’s annual Nobel Prize-focused colloquium on Oct. 14. This year’s event was particularly spec ...

The Dounreay site, opened about 70 years ago as the United Kingdom's hub for fast reactor research, has been undergoing decommissioning since the 1990s. The Office for Nuclear Regulation had ...

Scientists are seriously considering mimicking volcanic eruptions to mitigate global warming, but that comes with more than a ...

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

Perspective Therapeutics, Inc. (($CATX)) announced an update on their ongoing clinical study. Perspective Therapeutics, Inc. is conducting a ...

The South Atlantic Anomaly (SAA) is a particularly weak region of Earth’s magnetic field that can cause satellites to ...

Once considered a fringe idea, the prospect of offsetting global warming by releasing massive quantities of ...

Scientists are taking the once-radical concept of dimming the sun through stratospheric aerosol injection (SAI) seriously, ...

Scientists are questioning whether humanity can truly “dim the Sun” without causing chaos. A new University study shows that ...

Discover key insights from Luxfer Holdings’ Q3 2025 earnings call, including raised guidance, strong aerospace and defense growth, and major ...